HLS (HLS Therapeutics Inc) vs S&P TSX Composite Index (Canada) Comparison

HLS

S&P TSX Composite Index (Canada)

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

HLS

S&P TSX Composite Index (Canada)

Difference

1Y 3Y 5Y 10Y 15Y 20Y

HLS

S&P TSX Composite Index (Canada)

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

S&P TSX Composite Index (Canada)

HLS

MCK

COR

0HF3

CAH

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

HLS Therapeutics Inc
Glance View

Market Cap

122.4m CAD

Industry

Health Care

HLS Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Etobicoke, Ontario and currently employs 92 full-time employees. The firm is focused on developing clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. Its products include Vascepa, Trinomia, Clozaril, CSAN Pronto, PERSERIS and MyCare Psychiatry/MyCare Insite. Its lead product, Clozaril, is an atypical antipsychotic indicated in the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules reduce the risk of cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or hospitalization for unstable angina in statin-treated patients with elevated triglycerides.

View HLS Analysis

HLS Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US		Mckesson Corp NYSE:MCK	Select
US		Cencora Inc NYSE:COR	Select
US	A	Amerisourcebergen Corp LSE:0HF3	Select
US		Cardinal Health Inc NYSE:CAH	Select
US		Henry Schein Inc NASDAQ:HSIC	Select
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Select
CN		Sinopharm Group Co Ltd HKEX:1099	Select
CN		Huadong Medicine Co Ltd SZSE:000963	Select
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Select
IT		Amplifon SpA MIL:AMP	Select

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
LU		Tenaris SA MIL:TEN	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

	Franklin Covey Co NYSE:FC	30.78 USD -12.8%
	Mohawk Industries Inc NYSE:MHK	117.74 USD -0.46%
	Ardmore Shipping Corp NYSE:ASC	13.49 USD 7.4%
	ASGN Inc NYSE:ASGN	85.435 USD -1.71%
	Skyworks Solutions Inc NASDAQ:SWKS	91.24 USD -1.5%
	Weatherford International PLC NASDAQ:WFRD	71.32 USD -1.12%

HLS

vs

S&P TSX Composite Index (Canada)

Stocks Performance
HLS vs S&P TSX Composite Index (Canada)

Performance Gap
HLS vs S&P TSX Composite Index (Canada)

Performance By Year
HLS vs S&P TSX Composite Index (Canada)

Competitors Performance
HLS Therapeutics Inc vs Peers

HLS Therapeutics Inc
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.87 USD 0.42%
	Bank of America Corp NYSE:BAC	44.865 USD -2.91%
	Mastercard Inc NYSE:MA	504.22 USD -2.36%
	Salesforce Inc NYSE:CRM	318.01 USD -2.72%
	Abbvie Inc NYSE:ABBV	175.8852 USD -1.46%
	Home Depot Inc NYSE:HD	389.785 USD 0.67%

	Arista Networks Inc NYSE:ANET	113.68 USD -1.58%
	Visa Inc NYSE:V	306.44 USD -1.97%
	Texas Pacific Land Corp NYSE:TPL	1 297.79 USD 1.71%
	KLA Corp NASDAQ:KLAC	677.585 USD -1.26%
	Manhattan Associates Inc NASDAQ:MANH	263.91 USD -3.15%
	Pinduoduo Inc NASDAQ:PDD	95.34 USD -4.96%

	Salesforce Inc NYSE:CRM	318.01 USD -2.72%
	ServiceNow Inc NYSE:NOW	1 020.785 USD -2.7%
	EOG Resources Inc NYSE:EOG	131.125 USD 2.07%
	Copart Inc NASDAQ:CPRT	55.47 USD -2.31%
	Applied Materials Inc NASDAQ:AMAT	170.25 USD -3.81%
	Synopsys Inc NASDAQ:SNPS	485.5 USD -3.29%

	Johnson & Johnson NYSE:JNJ	142.87 USD 0.42%
	Berkshire Hathaway Inc NYSE:BRK.A	662 082.75 USD -2.34%
	Bank of America Corp NYSE:BAC	44.865 USD -2.91%
	Mastercard Inc NYSE:MA	504.22 USD -2.36%
	UnitedHealth Group Inc NYSE:UNH	525.11 USD 0.11%
	Exxon Mobil Corp NYSE:XOM	106.46 USD -0.44%

HLS vs S&P TSX Composite Index (Canada)

Stocks Performance HLS vs S&P TSX Composite Index (Canada)

Performance Gap HLS vs S&P TSX Composite Index (Canada)

Performance By Year HLS vs S&P TSX Composite Index (Canada)

Competitors Performance HLS Therapeutics Inc vs Peers

HLS Therapeutics Inc Glance View

Company

Help

Tools

Stocks

HLS

vs

S&P TSX Composite Index (Canada)

Stocks Performance
HLS vs S&P TSX Composite Index (Canada)

Performance Gap
HLS vs S&P TSX Composite Index (Canada)

Performance By Year
HLS vs S&P TSX Composite Index (Canada)

Competitors Performance
HLS Therapeutics Inc vs Peers

HLS Therapeutics Inc
Glance View